Non-Oncology Precision Medicine Market Analysis By Product (Diagnostics, Therapeutics), By Application (Oncology, CNS, Immunology, Respiratory, Infectious Diseases, Neurology, Other), By End User (Hospitals, Diagnostics Center, Research & Academic Institutes, Others) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Published date: May 2025
Report ID: 117276
Number of Pages: 237
Format:

Fact Checked

Cite this Research

- 1. Executive Summary
  - 1.1. Definition
  - 1.2. Market Snapshot
  - 1.3. Market Overview
  - 1.4. Segment Overview
  - 1.5. Regional Overview
  - 1.6. Competitive Landscape
  - 1.7. Taxonomy
- 2. Global Market Overview
  - 2.1. Global Market Insights and Industry Overview
  - 2.2. Market Dynamics
    
    2.2.1. Drivers
    
    2.2.2. Restraints
    
    2.2.3. Opportunities
    
    2.2.4. Key Non-Oncology Precision Medicine Market Trends
  - 2.3. Regulatory Framework
  - 2.4. Opportunity Map Analysis
  - 2.5. Opportunity Orbits
  - 2.6. PESTLE Analysis
  - 2.7. PORTER’S Five Force Analysis
  - 2.8. Drivers & Restraints Impact Analysis
  - 2.9. Value Chain Analysis
    
    2.9.1. List of Raw Materials Suppliers
    
    2.9.2. List of Non-Oncology Precision Medicine Manufacturers
    
    2.9.3. List of Dealer/Distributors
  - 2.10. Regional Market Share and BPS Analysis
  - 2.11. Impact of Macro-economic Factors/Geopolitical Factors
- 3. Global Non-Oncology Precision Medicine Market Analysis and Forecast, By Segment, 2020-2034
  - 3.1. Key Findings
  - 3.2. Global Non-Oncology Precision Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2020-2034
  - 3.3. Global Non-Oncology Precision Medicine Market Attractiveness Analysis, By Product
    
    3.3.1. Therapeutics
    
    3.3.1.1. Insights
    
    3.3.1.2. Key Takeaways
    
    3.3.2. Diagnostics
    
    3.3.2.1. Insights
    
    3.3.2.2. Key Takeaways
  - 3.4. Global Non-Oncology Precision Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  - 3.5. Global Non-Oncology Precision Medicine Market Attractiveness Analysis, By Application
    
    3.5.1. CNS
    
    3.5.1.1. Insights
    
    3.5.1.2. Key Takeaways
    
    3.5.2. Oncology
    
    3.5.2.1. Insights
    
    3.5.2.2. Key Takeaways
    
    3.5.3. Immunology
    
    3.5.3.1. Insights
    
    3.5.3.2. Key Takeaways
    
    3.5.4. Respiratory
    
    3.5.4.1. Insights
    
    3.5.4.2. Key Takeaways
    
    3.5.5. Infectious Diseases
    
    3.5.5.1. Insights
    
    3.5.5.2. Key Takeaways
    
    3.5.6. Neurology
    
    3.5.6.1. Insights
    
    3.5.6.2. Key Takeaways
    
    3.5.7. Other
    
    3.5.7.1. Insights
    
    3.5.7.2. Key Takeaways
  - 3.6. Global Non-Oncology Precision Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End User, 2020-2034
  - 3.7. Global Non-Oncology Precision Medicine Market Attractiveness Analysis, By End User
    
    3.7.1. Hospitals
    
    3.7.1.1. Insights
    
    3.7.1.2. Key Takeaways
    
    3.7.2. Diagnostics Center
    
    3.7.2.1. Insights
    
    3.7.2.2. Key Takeaways
    
    3.7.3. Research & Academic Institutes
    
    3.7.3.1. Insights
    
    3.7.3.2. Key Takeaways
    
    3.7.4. Others
    
    3.7.4.1. Insights
    
    3.7.4.2. Key Takeaways
- 4. Global Non-Oncology Precision Medicine Market Analysis and Forecast, By Region, 2020-2034
  - 4.1. Key Findings
  - 4.2. Global Non-Oncology Precision Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2020-2034
    
    4.2.1. North America
    
    4.2.1.1. Regional Insights
    
    4.2.2. Europe
    
    4.2.2.1. Regional Insights
    
    4.2.3. Asia Pacific
    
    4.2.3.1. Regional Insights
    
    4.2.4. Latin America
    
    4.2.4.1. Regional Insights
    
    4.2.5. Middle East & Africa
    
    4.2.5.1. Regional Insights
  - 4.3. Global Non-Oncology Precision Medicine Market Attractiveness Analysis, By Region
- 5. North America Non-Oncology Precision Medicine Market Analysis and Forecast, 2020-2034
  - 5.1. Key Findings
  - 5.2. North America Non-Oncology Precision Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2020-2034
  - 5.3. North America Non-Oncology Precision Medicine Market Attractiveness Analysis, By Product
  - 5.4. North America Non-Oncology Precision Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  - 5.5. North America Non-Oncology Precision Medicine Market Attractiveness Analysis, By Application
  - 5.6. North America Non-Oncology Precision Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End User, 2020-2034
  - 5.7. North America Non-Oncology Precision Medicine Market Attractiveness Analysis, By End User
  - 5.8. North America Non-Oncology Precision Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  - 5.9. North America Non-Oncology Precision Medicine Market Attractiveness Analysis, By Country
    
    5.9.1. The US
    
    5.9.2. Canada
- 6. Europe Non-Oncology Precision Medicine Market Analysis and Forecast, 2020-2034
  - 6.1. Key Findings
  - 6.2. Europe Non-Oncology Precision Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2020-2034
  - 6.3. Europe Non-Oncology Precision Medicine Market Attractiveness Analysis, By Product
  - 6.4. Europe Non-Oncology Precision Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  - 6.5. Europe Non-Oncology Precision Medicine Market Attractiveness Analysis, By Application
  - 6.6. Europe Non-Oncology Precision Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End User, 2020-2034
  - 6.7. Europe Non-Oncology Precision Medicine Market Attractiveness Analysis, By End User
  - 6.8. Europe Non-Oncology Precision Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  - 6.9. Europe Non-Oncology Precision Medicine Market Attractiveness Analysis, By Country
    
    6.9.1. Germany
    
    6.9.2. The UK
    
    6.9.3. France
    
    6.9.4. Spain
    
    6.9.5. Italy
    
    6.9.6. Russia
    
    6.9.7. Netherland
    
    6.9.8. Rest of Europe
- 7. Asia Pacific Non-Oncology Precision Medicine Market Analysis and Forecast, 2020-2034
  - 7.1. Key Findings
  - 7.2. Asia Pacific Non-Oncology Precision Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2020-2034
  - 7.3. Asia Pacific Non-Oncology Precision Medicine Market Attractiveness Analysis, By Product
  - 7.4. Asia Pacific Non-Oncology Precision Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  - 7.5. Asia Pacific Non-Oncology Precision Medicine Market Attractiveness Analysis, By Application
  - 7.6. Asia Pacific Non-Oncology Precision Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End User, 2020-2034
  - 7.7. Asia Pacific Non-Oncology Precision Medicine Market Attractiveness Analysis, By End User
  - 7.8. Asia Pacific Non-Oncology Precision Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  - 7.9. Asia Pacific Non-Oncology Precision Medicine Market Attractiveness Analysis, By Country
    
    7.9.1. China
    
    7.9.2. Japan
    
    7.9.3. South Korea
    
    7.9.4. India
    
    7.9.5. Australia
    
    7.9.6. New Zealand
    
    7.9.7. Singapore
    
    7.9.8. Thailand
    
    7.9.9. Vietnam
    
    7.9.10. Rest of Asia Pacific
- 8. Latin America Non-Oncology Precision Medicine Market Analysis and Forecast, 2020-2034
  - 8.1. Key Findings
  - 8.2. Latin America Non-Oncology Precision Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2020-2034
  - 8.3. Latin America Non-Oncology Precision Medicine Market Attractiveness Analysis, By Product
  - 8.4. Latin America Non-Oncology Precision Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  - 8.5. Latin America Non-Oncology Precision Medicine Market Attractiveness Analysis, By Application
  - 8.6. Latin America Non-Oncology Precision Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End User, 2020-2034
  - 8.7. Latin America Non-Oncology Precision Medicine Market Attractiveness Analysis, By End User
  - 8.8. Latin America Non-Oncology Precision Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  - 8.9. Latin America Non-Oncology Precision Medicine Market Attractiveness Analysis, By Country
    
    8.9.1. Brazil
    
    8.9.2. Mexico
    
    8.9.3. Rest of Latin America
- 9. Middle East & Africa Non-Oncology Precision Medicine Market Analysis and Forecast, 2020-2034
  - 9.1. Key Findings
  - 9.2. Middle East & Africa Non-Oncology Precision Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2020-2034
  - 9.3. Middle East & Africa Non-Oncology Precision Medicine Market Attractiveness Analysis, By Product
  - 9.4. Middle East & Africa Non-Oncology Precision Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  - 9.5. Middle East & Africa Non-Oncology Precision Medicine Market Attractiveness Analysis, By Application
  - 9.6. Middle East & Africa Non-Oncology Precision Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End User, 2020-2034
  - 9.7. Middle East & Africa Non-Oncology Precision Medicine Market Attractiveness Analysis, By End User
  - 9.8. Middle East & Africa Non-Oncology Precision Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  - 9.9. Middle East & Africa Non-Oncology Precision Medicine Market Attractiveness Analysis, By Country
    
    9.9.1. South Africa
    
    9.9.2. Saudi Arabia
    
    9.9.3. UAE
    
    9.9.4. Rest of Middle East & Africa
- 10. Competitive Landscape & Company Profiles
  - 10.1. Market Competition Scenario Analysis, By Company
    
    10.1.1. Key Takeaways
  - 10.2. Overview of Major Market Players
  - 10.3. Competitor Landscape
  - 10.4. Strategic Mapping
  - 10.5. Company Life Cycle Analysis
  - 10.6. Company Market Share Analysis
  - 10.7. Company Profiles
    
    10.7.1. Pfizer Inc.
    
    10.7.1.1. Company Details
    
    10.7.1.2. Business Overview
    
    10.7.1.3. Product Portfolio
    
    10.7.1.4. Financial Insights
    
    10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.1.6. SWOT Analysis
    
    10.7.1.7. Geographic Footprint
    
    10.7.2. Abbott Laboratories
    
    10.7.2.1. Company Details
    
    10.7.2.2. Business Overview
    
    10.7.2.3. Product Portfolio
    
    10.7.2.4. Financial Insights
    
    10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.2.6. SWOT Analysis
    
    10.7.2.7. Geographic Footprint
    
    10.7.3. Medtronic
    
    10.7.3.1. Company Details
    
    10.7.3.2. Business Overview
    
    10.7.3.3. Product Portfolio
    
    10.7.3.4. Financial Insights
    
    10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.3.6. SWOT Analysis
    
    10.7.3.7. Geographic Footprint
    
    10.7.4. Novartis
    
    10.7.4.1. Company Details
    
    10.7.4.2. Business Overview
    
    10.7.4.3. Product Portfolio
    
    10.7.4.4. Financial Insights
    
    10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.4.6. SWOT Analysis
    
    10.7.4.7. Geographic Footprint
    
    10.7.5. Eli Lilly & Company
    
    10.7.5.1. Company Details
    
    10.7.5.2. Business Overview
    
    10.7.5.3. Product Portfolio
    
    10.7.5.4. Financial Insights
    
    10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.5.6. SWOT Analysis
    
    10.7.5.7. Geographic Footprint
    
    10.7.6. Laboratory Corporation of America Holdings
    
    10.7.6.1. Company Details
    
    10.7.6.2. Business Overview
    
    10.7.6.3. Product Portfolio
    
    10.7.6.4. Financial Insights
    
    10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.6.6. SWOT Analysis
    
    10.7.6.7. Geographic Footprint
    
    10.7.7. Qiagen, Inc.
    
    10.7.7.1. Company Details
    
    10.7.7.2. Business Overview
    
    10.7.7.3. Product Portfolio
    
    10.7.7.4. Financial Insights
    
    10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.7.6. SWOT Analysis
    
    10.7.7.7. Geographic Footprint
    
    10.7.8. Quest Diagnostics Inc.
    
    10.7.8.1. Company Details
    
    10.7.8.2. Business Overview
    
    10.7.8.3. Product Portfolio
    
    10.7.8.4. Financial Insights
    
    10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.8.6. SWOT Analysis
    
    10.7.8.7. Geographic Footprint
    
    10.7.9. Bristol Myers Squibb
    
    10.7.9.1. Company Details
    
    10.7.9.2. Business Overview
    
    10.7.9.3. Product Portfolio
    
    10.7.9.4. Financial Insights
    
    10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.9.6. SWOT Analysis
    
    10.7.9.7. Geographic Footprint
    
    10.7.10. Danaher Corporation
    
    10.7.10.1. Company Details
    
    10.7.10.2. Business Overview
    
    10.7.10.3. Product Portfolio
    
    10.7.10.4. Financial Insights
    
    10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.10.6. SWOT Analysis
    
    10.7.10.7. Geographic Footprint
- 11. Methodology and Data Source
  - 11.1. Methodology/Research Approach
  - 11.2. Market Size Estimation
  - 11.3. Market Breakdown and Data Triangulation
  - 11.4. Data Source
  - 11.5. Secondary Sources
  - 11.6. Primary Sources
  - 11.7. Appendix
  - 11.8. Disclaimer
- List of Tables
  - Table 1. Global Non-Oncology Precision Medicine Market Value (US$ Mn), By Product, 2020-2034
  - Table 2. Global Non-Oncology Precision Medicine Market Value (US$ Mn), By Application, 2020-2034
  - Table 3. Global Non-Oncology Precision Medicine Market Value (US$ Mn), By End User, 2020-2034
  - Table 4. Global Non-Oncology Precision Medicine Market Value (US$ Mn), By Region, 2020-2034
  - Table 5. North America Non-Oncology Precision Medicine Market Value (US$ Mn), By Product, 2020-2034
  - Table 6. North America Non-Oncology Precision Medicine Market Value (US$ Mn), By Application, 2020-2034
  - Table 7. North America Non-Oncology Precision Medicine Market Value (US$ Mn), By End User, 2020-2034
  - Table 8. North America Non-Oncology Precision Medicine Market Value (US$ Mn), By Country, 2020-2034
  - Table 9. The US Non-Oncology Precision Medicine Market Value (US$ Mn), By Product, 2020-2034
  - Table 10. The US Non-Oncology Precision Medicine Market Value (US$ Mn), By Application, 2020-2034
  - Table 11. The US Non-Oncology Precision Medicine Market Value (US$ Mn), By End User, 2020-2034
  - Table 12. Canada Non-Oncology Precision Medicine Market Value (US$ Mn), By Product, 2020-2034
  - Table 13. Canada Non-Oncology Precision Medicine Market Value (US$ Mn), By Application, 2020-2034
  - Table 14. Canada Non-Oncology Precision Medicine Market Value (US$ Mn), By End User, 2020-2034
  - Table 15. Europe Non-Oncology Precision Medicine Market Value (US$ Mn), By Product, 2020-2034
  - Table 16. Europe Non-Oncology Precision Medicine Market Value (US$ Mn), By Application, 2020-2034
  - Table 17. Europe Non-Oncology Precision Medicine Market Value (US$ Mn), By End User, 2020-2034
  - Table 18. Europe Non-Oncology Precision Medicine Market Value (US$ Mn), By Country, 2020-2034
  - Table 19. Germany Non-Oncology Precision Medicine Market Value (US$ Mn), By Product, 2020-2034
  - Table 20. Germany Non-Oncology Precision Medicine Market Value (US$ Mn), By Application, 2020-2034
  - Table 21. Germany Non-Oncology Precision Medicine Market Value (US$ Mn), By End User, 2020-2034
  - Table 22. The UK Non-Oncology Precision Medicine Market Value (US$ Mn), By Product, 2020-2034
  - Table 23. The UK Non-Oncology Precision Medicine Market Value (US$ Mn), By Application, 2020-2034
  - Table 24. The UK Non-Oncology Precision Medicine Market Value (US$ Mn), By End User, 2020-2034
  - Table 25. France Non-Oncology Precision Medicine Market Value (US$ Mn), By Product, 2020-2034
  - Table 26. France Non-Oncology Precision Medicine Market Value (US$ Mn), By Application, 2020-2034
  - Table 27. France Non-Oncology Precision Medicine Market Value (US$ Mn), By End User, 2020-2034
  - Table 28. Spain Non-Oncology Precision Medicine Market Value (US$ Mn), By Product, 2020-2034
  - Table 29. Spain Non-Oncology Precision Medicine Market Value (US$ Mn), By Application, 2020-2034
  - Table 30. Spain Non-Oncology Precision Medicine Market Value (US$ Mn), By End User, 2020-2034
  - Table 31. Italy Non-Oncology Precision Medicine Market Value (US$ Mn), By Product, 2020-2034
  - Table 32. Italy Non-Oncology Precision Medicine Market Value (US$ Mn), By Application, 2020-2034
  - Table 33. Italy Non-Oncology Precision Medicine Market Value (US$ Mn), By End User, 2020-2034
  - Table 34. Russia Non-Oncology Precision Medicine Market Value (US$ Mn), By Product, 2020-2034
  - Table 35. Russia Non-Oncology Precision Medicine Market Value (US$ Mn), By Application, 2020-2034
  - Table 36. Russia Non-Oncology Precision Medicine Market Value (US$ Mn), By End User, 2020-2034
  - Table 37. Netherland Non-Oncology Precision Medicine Market Value (US$ Mn), By Product, 2020-2034
  - Table 38. Netherland Non-Oncology Precision Medicine Market Value (US$ Mn), By Application, 2020-2034
  - Table 39. Netherland Non-Oncology Precision Medicine Market Value (US$ Mn), By End User, 2020-2034
  - Table 40. Rest of Europe Non-Oncology Precision Medicine Market Value (US$ Mn), By Product, 2020-2034
  - Table 41. Rest of Europe Non-Oncology Precision Medicine Market Value (US$ Mn), By Application, 2020-2034
  - Table 42. Rest of Europe Non-Oncology Precision Medicine Market Value (US$ Mn), By End User, 2020-2034
  - Table 43. Asia Pacific Non-Oncology Precision Medicine Market Value (US$ Mn), By Product, 2020-2034
  - Table 44. Asia Pacific Non-Oncology Precision Medicine Market Value (US$ Mn), By Application, 2020-2034
  - Table 45. Asia Pacific Non-Oncology Precision Medicine Market Value (US$ Mn), By End User, 2020-2034
  - Table 46. Asia Pacific Non-Oncology Precision Medicine Market Value (US$ Mn), By Country, 2020-2034
  - Table 47. China Non-Oncology Precision Medicine Market Value (US$ Mn), By Product, 2020-2034
  - Table 48. China Non-Oncology Precision Medicine Market Value (US$ Mn), By Application, 2020-2034
  - Table 49. China Non-Oncology Precision Medicine Market Value (US$ Mn), By End User, 2020-2034
  - Table 50. India Non-Oncology Precision Medicine Market Value (US$ Mn), By Product, 2020-2034
  - Table 51. India Non-Oncology Precision Medicine Market Value (US$ Mn), By Application, 2020-2034
  - Table 52. India Non-Oncology Precision Medicine Market Value (US$ Mn), By End User, 2020-2034
  - Table 53. Japan Non-Oncology Precision Medicine Market Value (US$ Mn), By Product, 2020-2034
  - Table 54. Japan Non-Oncology Precision Medicine Market Value (US$ Mn), By Application, 2020-2034
  - Table 55. Japan Non-Oncology Precision Medicine Market Value (US$ Mn), By End User, 2020-2034
  - Table 56. South Korea Non-Oncology Precision Medicine Market Value (US$ Mn), By Product, 2020-2034
  - Table 57. South Korea Non-Oncology Precision Medicine Market Value (US$ Mn), By Application, 2020-2034
  - Table 58. South Korea Non-Oncology Precision Medicine Market Value (US$ Mn), By End User, 2020-2034
  - Table 59. Australia Non-Oncology Precision Medicine Market Value (US$ Mn), By Product, 2020-2034
  - Table 60. Australia Non-Oncology Precision Medicine Market Value (US$ Mn), By Application, 2020-2034
  - Table 61. Australia Non-Oncology Precision Medicine Market Value (US$ Mn), By End User, 2020-2034
  - Table 62. New Zealand Non-Oncology Precision Medicine Market Value (US$ Mn), By Product, 2020-2034
  - Table 63. New Zealand Non-Oncology Precision Medicine Market Value (US$ Mn), By Application, 2020-2034
  - Table 64. New Zealand Non-Oncology Precision Medicine Market Value (US$ Mn), By End User, 2020-2034
  - Table 65. Singapore Non-Oncology Precision Medicine Market Value (US$ Mn), By Product, 2020-2034
  - Table 66. Singapore Non-Oncology Precision Medicine Market Value (US$ Mn), By Application, 2020-2034
  - Table 67. Singapore Non-Oncology Precision Medicine Market Value (US$ Mn), By End User, 2020-2034
  - Table 68. Thailand Non-Oncology Precision Medicine Market Value (US$ Mn), By Product, 2020-2034
  - Table 69. Thailand Non-Oncology Precision Medicine Market Value (US$ Mn), By Application, 2020-2034
  - Table 70. Thailand Non-Oncology Precision Medicine Market Value (US$ Mn), By End User, 2020-2034
  - Table 71. Vietnam Non-Oncology Precision Medicine Market Value (US$ Mn), By Product, 2020-2034
  - Table 72. Vietnam Non-Oncology Precision Medicine Market Value (US$ Mn), By Application, 2020-2034
  - Table 73. Vietnam Non-Oncology Precision Medicine Market Value (US$ Mn), By End User, 2020-2034
  - Table 74. Rest of Asia Pacific Non-Oncology Precision Medicine Market Value (US$ Mn), By Product, 2020-2034
  - Table 75. Rest of Asia Pacific Non-Oncology Precision Medicine Market Value (US$ Mn), By Application, 2020-2034
  - Table 76. Rest of Asia Pacific Non-Oncology Precision Medicine Market Value (US$ Mn), By End User, 2020-2034
  - Table 77. Latin America Non-Oncology Precision Medicine Market Value (US$ Mn), By Product, 2020-2034
  - Table 78. Latin America Non-Oncology Precision Medicine Market Value (US$ Mn), By Application, 2020-2034
  - Table 79. Latin America Non-Oncology Precision Medicine Market Value (US$ Mn), By End User, 2020-2034
  - Table 80. Latin America Non-Oncology Precision Medicine Market Value (US$ Mn), By Country, 2020-2034
  - Table 81. Brazil Non-Oncology Precision Medicine Market Value (US$ Mn), By Product, 2020-2034
  - Table 82. Brazil Non-Oncology Precision Medicine Market Value (US$ Mn), By Application, 2020-2034
  - Table 83. Brazil Non-Oncology Precision Medicine Market Value (US$ Mn), By End User, 2020-2034
  - Table 84. Mexico Non-Oncology Precision Medicine Market Value (US$ Mn), By Product, 2020-2034
  - Table 85. Mexico Non-Oncology Precision Medicine Market Value (US$ Mn), By Application, 2020-2034
  - Table 86. Mexico Non-Oncology Precision Medicine Market Value (US$ Mn), By End User, 2020-2034
  - Table 87. Rest of Latin America Non-Oncology Precision Medicine Market Value (US$ Mn), By Product, 2020-2034
  - Table 88. Rest of Latin America Non-Oncology Precision Medicine Market Value (US$ Mn), By Application, 2020-2034
  - Table 89. Rest of Latin America Non-Oncology Precision Medicine Market Value (US$ Mn), By End User, 2020-2034
  - Table 90. Middle East & Africa Non-Oncology Precision Medicine Market Value (US$ Mn), By Product, 2020-2034
  - Table 91. Middle East & Africa Non-Oncology Precision Medicine Market Value (US$ Mn), By Application, 2020-2034
  - Table 92. Middle East & Africa Non-Oncology Precision Medicine Market Value (US$ Mn), By End User, 2020-2034
  - Table 93. Middle East & Africa Non-Oncology Precision Medicine Market Value (US$ Mn), By Country, 2020-2034
  - Table 94. South Africa Non-Oncology Precision Medicine Market Value (US$ Mn), By Product, 2020-2034
  - Table 95. South Africa Non-Oncology Precision Medicine Market Value (US$ Mn), By Application, 2020-2034
  - Table 96. South Africa Non-Oncology Precision Medicine Market Value (US$ Mn), By End User, 2020-2034
  - Table 97. Saudi Arabia Non-Oncology Precision Medicine Market Value (US$ Mn), By Product, 2020-2034
  - Table 98. Saudi Arabia Non-Oncology Precision Medicine Market Value (US$ Mn), By Application, 2020-2034
  - Table 99. Saudi Arabia Non-Oncology Precision Medicine Market Value (US$ Mn), By End User, 2020-2034
  - Table 100. UAE Non-Oncology Precision Medicine Market Value (US$ Mn), By Product, 2020-2034
  - Table 101. UAE Non-Oncology Precision Medicine Market Value (US$ Mn), By Application, 2020-2034
  - Table 102. UAE Non-Oncology Precision Medicine Market Value (US$ Mn), By End User, 2020-2034
  - Table 103. Rest of Middle East & Africa Non-Oncology Precision Medicine Market Value (US$ Mn), By Product, 2020-2034
  - Table 104. Rest of Middle East & Africa Non-Oncology Precision Medicine Market Value (US$ Mn), By Application, 2020-2034
  - Table 105. Rest of Middle East & Africa Non-Oncology Precision Medicine Market Value (US$ Mn), By End User, 2020-2034
- List of Figures
  - Figure 1. Global Non-Oncology Precision Medicine Market Snapshot: Market Value (US$ Mn), 2020-2034
  - Figure 2. Opportunity Map
  - Figure 3. Opportunity Orbit
  - Figure 4. Regional Market Share and BPS Analysis in Non-Oncology Precision Medicine Market
  - Figure 5. Global Non-Oncology Precision Medicine Market Analysis, By Product, 2020, 2024 and 2034
  - Figure 6. Global Non-Oncology Precision Medicine Market Attractiveness Analysis, By Product
  - Figure 7. Global Non-Oncology Precision Medicine Market Analysis, By Application, 2020, 2024 and 2034
  - Figure 8. Global Non-Oncology Precision Medicine Market Attractiveness Analysis, By Application
  - Figure 9. Global Non-Oncology Precision Medicine Market Analysis, By End User, 2020, 2024 and 2034
  - Figure 10. Global Non-Oncology Precision Medicine Market Attractiveness Analysis, By End User
  - Figure 11. Global Non-Oncology Precision Medicine Market Analysis, By Region, 2020, 2024 and 2034
  - Figure 12. Global Non-Oncology Precision Medicine Market Attractiveness Analysis, By Region
  - Figure 13. North America Non-Oncology Precision Medicine Market Analysis, By Product, 2020, 2024 and 2034
  - Figure 14. North America Non-Oncology Precision Medicine Market Attractiveness Analysis, By Product
  - Figure 15. North America Non-Oncology Precision Medicine Market (US$ Mn), by Therapeutics, 2020-2034
  - Figure 16. North America Non-Oncology Precision Medicine Market (US$ Mn), by Diagnostics, 2020-2034
  - Figure 17. North America Non-Oncology Precision Medicine Market Analysis, By Application, 2020, 2024 and 2034
  - Figure 18. North America Non-Oncology Precision Medicine Market Attractiveness Analysis, By Application
  - Figure 19. North America Non-Oncology Precision Medicine Market (US$ Mn), by CNS, 2020-2034
  - Figure 20. North America Non-Oncology Precision Medicine Market (US$ Mn), by Oncology, 2020-2034
  - Figure 21. North America Non-Oncology Precision Medicine Market (US$ Mn), by Immunology, 2020-2034
  - Figure 22. North America Non-Oncology Precision Medicine Market (US$ Mn), by Respiratory, 2020-2034
  - Figure 23. North America Non-Oncology Precision Medicine Market (US$ Mn), by Infectious Diseases, 2020-2034
  - Figure 24. North America Non-Oncology Precision Medicine Market (US$ Mn), by Neurology, 2020-2034
  - Figure 25. North America Non-Oncology Precision Medicine Market (US$ Mn), by Other, 2020-2034
  - Figure 26. North America Non-Oncology Precision Medicine Market Analysis, By End User, 2020, 2024 and 2034
  - Figure 27. North America Non-Oncology Precision Medicine Market Attractiveness Analysis, By End User
  - Figure 28. North America Non-Oncology Precision Medicine Market (US$ Mn), by Hospitals, 2020-2034
  - Figure 29. North America Non-Oncology Precision Medicine Market (US$ Mn), by Diagnostics Center, 2020-2034
  - Figure 30. North America Non-Oncology Precision Medicine Market (US$ Mn), by Research & Academic Institutes, 2020-2034
  - Figure 31. North America Non-Oncology Precision Medicine Market (US$ Mn), by Others, 2020-2034
  - Figure 32. North America Non-Oncology Precision Medicine Market Analysis, By Country, 2020, 2024 and 2034
  - Figure 33. North America Non-Oncology Precision Medicine Market Attractiveness Analysis, By Country
  - Figure 34. Europe Non-Oncology Precision Medicine Market Analysis, By Product, 2020, 2024 and 2034
  - Figure 35. Europe Non-Oncology Precision Medicine Market Attractiveness Analysis, By Product
  - Figure 36. Europe Non-Oncology Precision Medicine Market (US$ Mn), by Therapeutics, 2020-2034
  - Figure 37. Europe Non-Oncology Precision Medicine Market (US$ Mn), by Diagnostics, 2020-2034
  - Figure 38. Europe Non-Oncology Precision Medicine Market Analysis, By Application, 2020, 2024 and 2034
  - Figure 39. Europe Non-Oncology Precision Medicine Market Attractiveness Analysis, By Application
  - Figure 40. Europe Non-Oncology Precision Medicine Market (US$ Mn), by CNS, 2020-2034
  - Figure 41. Europe Non-Oncology Precision Medicine Market (US$ Mn), by Oncology, 2020-2034
  - Figure 42. Europe Non-Oncology Precision Medicine Market (US$ Mn), by Immunology, 2020-2034
  - Figure 43. Europe Non-Oncology Precision Medicine Market (US$ Mn), by Respiratory, 2020-2034
  - Figure 44. Europe Non-Oncology Precision Medicine Market (US$ Mn), by Infectious Diseases, 2020-2034
  - Figure 45. Europe Non-Oncology Precision Medicine Market (US$ Mn), by Neurology, 2020-2034
  - Figure 46. Europe Non-Oncology Precision Medicine Market (US$ Mn), by Other, 2020-2034
  - Figure 47. Europe Non-Oncology Precision Medicine Market Analysis, By End User, 2020, 2024 and 2034
  - Figure 48. Europe Non-Oncology Precision Medicine Market Attractiveness Analysis, By End User
  - Figure 49. Europe Non-Oncology Precision Medicine Market (US$ Mn), by Hospitals, 2020-2034
  - Figure 50. Europe Non-Oncology Precision Medicine Market (US$ Mn), by Diagnostics Center, 2020-2034
  - Figure 51. Europe Non-Oncology Precision Medicine Market (US$ Mn), by Research & Academic Institutes, 2020-2034
  - Figure 52. Europe Non-Oncology Precision Medicine Market (US$ Mn), by Others, 2020-2034
  - Figure 53. Europe Non-Oncology Precision Medicine Market Analysis, By Country, 2020, 2024 and 2034
  - Figure 54. Europe Non-Oncology Precision Medicine Market Attractiveness Analysis, By Country
  - Figure 55. Asia Pacific Non-Oncology Precision Medicine Market Analysis, By Product, 2020, 2024 and 2034
  - Figure 56. Asia Pacific Non-Oncology Precision Medicine Market Attractiveness Analysis, By Product
  - Figure 57. Asia Pacific Non-Oncology Precision Medicine Market (US$ Mn), by Therapeutics, 2020-2034
  - Figure 58. Asia Pacific Non-Oncology Precision Medicine Market (US$ Mn), by Diagnostics, 2020-2034
  - Figure 59. Asia Pacific Non-Oncology Precision Medicine Market Analysis, By Application, 2020, 2024 and 2034
  - Figure 60. Asia Pacific Non-Oncology Precision Medicine Market Attractiveness Analysis, By Application
  - Figure 61. Asia Pacific Non-Oncology Precision Medicine Market (US$ Mn), by CNS, 2020-2034
  - Figure 62. Asia Pacific Non-Oncology Precision Medicine Market (US$ Mn), by Oncology, 2020-2034
  - Figure 63. Asia Pacific Non-Oncology Precision Medicine Market (US$ Mn), by Immunology, 2020-2034
  - Figure 64. Asia Pacific Non-Oncology Precision Medicine Market (US$ Mn), by Respiratory, 2020-2034
  - Figure 65. Asia Pacific Non-Oncology Precision Medicine Market (US$ Mn), by Infectious Diseases, 2020-2034
  - Figure 66. Asia Pacific Non-Oncology Precision Medicine Market (US$ Mn), by Neurology, 2020-2034
  - Figure 67. Asia Pacific Non-Oncology Precision Medicine Market (US$ Mn), by Other, 2020-2034
  - Figure 68. Asia Pacific Non-Oncology Precision Medicine Market Analysis, By End User, 2020, 2024 and 2034
  - Figure 69. Asia Pacific Non-Oncology Precision Medicine Market Attractiveness Analysis, By End User
  - Figure 70. Asia Pacific Non-Oncology Precision Medicine Market (US$ Mn), by Hospitals, 2020-2034
  - Figure 71. Asia Pacific Non-Oncology Precision Medicine Market (US$ Mn), by Diagnostics Center, 2020-2034
  - Figure 72. Asia Pacific Non-Oncology Precision Medicine Market (US$ Mn), by Research & Academic Institutes, 2020-2034
  - Figure 73. Asia Pacific Non-Oncology Precision Medicine Market (US$ Mn), by Others, 2020-2034
  - Figure 74. Asia Pacific Non-Oncology Precision Medicine Market Analysis, By Country, 2020, 2024 and 2034
  - Figure 75. Asia Pacific Non-Oncology Precision Medicine Market Attractiveness Analysis, By Country
  - Figure 76. Latin America Non-Oncology Precision Medicine Market Analysis, By Product, 2020, 2024 and 2034
  - Figure 77. Latin America Non-Oncology Precision Medicine Market Attractiveness Analysis, By Product
  - Figure 78. Latin America Non-Oncology Precision Medicine Market (US$ Mn), by Therapeutics, 2020-2034
  - Figure 79. Latin America Non-Oncology Precision Medicine Market (US$ Mn), by Diagnostics, 2020-2034
  - Figure 80. Latin America Non-Oncology Precision Medicine Market Analysis, By Application, 2020, 2024 and 2034
  - Figure 81. Latin America Non-Oncology Precision Medicine Market Attractiveness Analysis, By Application
  - Figure 82. Latin America Non-Oncology Precision Medicine Market (US$ Mn), by CNS, 2020-2034
  - Figure 83. Latin America Non-Oncology Precision Medicine Market (US$ Mn), by Oncology, 2020-2034
  - Figure 84. Latin America Non-Oncology Precision Medicine Market (US$ Mn), by Immunology, 2020-2034
  - Figure 85. Latin America Non-Oncology Precision Medicine Market (US$ Mn), by Respiratory, 2020-2034
  - Figure 86. Latin America Non-Oncology Precision Medicine Market (US$ Mn), by Infectious Diseases, 2020-2034
  - Figure 87. Latin America Non-Oncology Precision Medicine Market (US$ Mn), by Neurology, 2020-2034
  - Figure 88. Latin America Non-Oncology Precision Medicine Market (US$ Mn), by Other, 2020-2034
  - Figure 89. Latin America Non-Oncology Precision Medicine Market Analysis, By End User, 2020, 2024 and 2034
  - Figure 90. Latin America Non-Oncology Precision Medicine Market Attractiveness Analysis, By End User
  - Figure 91. Latin America Non-Oncology Precision Medicine Market (US$ Mn), by Hospitals, 2020-2034
  - Figure 92. Latin America Non-Oncology Precision Medicine Market (US$ Mn), by Diagnostics Center, 2020-2034
  - Figure 93. Latin America Non-Oncology Precision Medicine Market (US$ Mn), by Research & Academic Institutes, 2020-2034
  - Figure 94. Latin America Non-Oncology Precision Medicine Market (US$ Mn), by Others, 2020-2034
  - Figure 95. Latin America Non-Oncology Precision Medicine Market Analysis, By Country, 2020, 2024 and 2034
  - Figure 96. Latin America Non-Oncology Precision Medicine Market Attractiveness Analysis, By Country
  - Figure 97. Middle East & Africa Non-Oncology Precision Medicine Market Analysis, By Product, 2020, 2024 and 2034
  - Figure 98. Middle East & Africa Non-Oncology Precision Medicine Market Attractiveness Analysis, By Product
  - Figure 99. Middle East & Africa Non-Oncology Precision Medicine Market (US$ Mn), by Therapeutics, 2020-2034
  - Figure 100. Middle East & Africa Non-Oncology Precision Medicine Market (US$ Mn), by Diagnostics, 2020-2034
  - Figure 101. Middle East & Africa Non-Oncology Precision Medicine Market Analysis, By Application, 2020, 2024 and 2034
  - Figure 102. Middle East & Africa Non-Oncology Precision Medicine Market Attractiveness Analysis, By Application
  - Figure 103. Middle East & Africa Non-Oncology Precision Medicine Market (US$ Mn), by CNS, 2020-2034
  - Figure 104. Middle East & Africa Non-Oncology Precision Medicine Market (US$ Mn), by Oncology, 2020-2034
  - Figure 105. Middle East & Africa Non-Oncology Precision Medicine Market (US$ Mn), by Immunology, 2020-2034
  - Figure 106. Middle East & Africa Non-Oncology Precision Medicine Market (US$ Mn), by Respiratory, 2020-2034
  - Figure 107. Middle East & Africa Non-Oncology Precision Medicine Market (US$ Mn), by Infectious Diseases, 2020-2034
  - Figure 108. Middle East & Africa Non-Oncology Precision Medicine Market (US$ Mn), by Neurology, 2020-2034
  - Figure 109. Middle East & Africa Non-Oncology Precision Medicine Market (US$ Mn), by Other, 2020-2034
  - Figure 110. Middle East & Africa Non-Oncology Precision Medicine Market Analysis, By End User, 2020, 2024 and 2034
  - Figure 111. Middle East & Africa Non-Oncology Precision Medicine Market Attractiveness Analysis, By End User
  - Figure 112. Middle East & Africa Non-Oncology Precision Medicine Market (US$ Mn), by Hospitals, 2020-2034
  - Figure 113. Middle East & Africa Non-Oncology Precision Medicine Market (US$ Mn), by Diagnostics Center, 2020-2034
  - Figure 114. Middle East & Africa Non-Oncology Precision Medicine Market (US$ Mn), by Research & Academic Institutes, 2020-2034
  - Figure 115. Middle East & Africa Non-Oncology Precision Medicine Market (US$ Mn), by Others, 2020-2034
  - Figure 116. Middle East & Africa Non-Oncology Precision Medicine Market Analysis, By Country, 2020, 2024 and 2034
  - Figure 117. Middle East & Africa Non-Oncology Precision Medicine Market Attractiveness Analysis, By Country
- Pfizer Inc.
- Abbott Laboratories
- Medtronic
- Novartis
- Eli Lilly & Company
- Laboratory Corporation of America Holdings
- Qiagen Inc.
- Quest Diagnostics Inc.
- Bristol Myers Squibb
- Danaher Corporation